Skip to main content
European Commission logo
English English
CORDIS - EU research results
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Training AlliancE for Novel Microbiome-Modulating TherapieS

Project description

Drug discovery training platform with a focus on microbiota therapeutic modifications

Funded by the Marie Skłodowska-Curie Actions programme, the TALENTS project aims to build an international alliance for the interdisciplinary training of 15 doctoral candidates as next-generation drug researchers. Individual projects are structured to focus on the investigation of the microbiome and therapeutic modifications of the microbiota, alternatives to traditional antibiotics to lower the risk of resistance development, and means of delivering new therapeutic agents. The overarching goal is to develop new disease models and analytical methods. Discovering correlations and links between microbiota and disease origination, TALENTS will advance the discovery of innovative microbiome-modulating therapies.

Objective

TALENTS aims to build up an international programme for interdisciplinary and transsectorial training of 15 doctoral candidates (DCs) as needed for the next generation of drug researchers. Research projects are structured in 3 clusters (PCs): PC1 will investigate the microbiome by transcriptomic and metagenomic analysis of diseases to identify and isolate microorganisms/metabolites for therapeutically modifying the microbiota. PC2 will focus on pathoblockers targeting virulence factors as alternative to traditional antibiotics with lower risk of resistance development. PC3 will address the delivery needs across biological barriers, to achieve efficient and targeted transport to the site of action. Throughout the PC structure of 15 individual, but interconnected research projects, we aim to develop and exchange disease models, analytical methods and microbiome-related results. By generating knowledge on correlations and causalities between microbiota and disease TALENTS will advance the development of novel microbiome-modulating therapies
TALENTS is builds on an earlier joint venture of Saarland University, University Clinics Saarland and Helmholtz Institute for Pharmaceutical Research Saarland to foster transdisciplinary doctoral training between different faculties and institutions. In addition, TALENTS is intersectorial by implementing a unique supervision structure for each DC with an external expert advisor and translation-oriented training for individual career development, also including secondments in a complementary industrial or clinical sector. Working on challenging research projects, the candidates will acquire specific knowledge and skills at the interface of clinical medicine, microbiology and pharmaceutical science, pivotal for state-of-the-art infection research and microbiome interventions.
By collaborations of experts from natural sciences, medicine, and bioinformatics, TALENTS provides high-level multidisciplinary and intersectorial training.

Coordinator

UNIVERSITAT DES SAARLANDES
Net EU contribution
€ 1 512 000,00
Address
CAMPUS
66123 Saarbrucken
Germany

See on map

Region
Saarland Saarland Regionalverband Saarbrücken
Activity type
Higher or Secondary Education Establishments
Links
Total cost
No data

Partners (16)